Doria (risperidone extended release) / ROVI Pharmaceuticals Laboratories 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Doria (risperidone extended release) / ROVI Pharmaceuticals Laboratories
QUARTZ, NCT06276361: Pharmacokinetics, Safety and Tolerability of Different Formulations and Dose Strengths of Quarterly Risperidone (QUAR) in Patients With Schizophrenia

Recruiting
1
100
RoW
Oral risperidone; QUAR F1/2, Dose 1 - Gluteal, Oral risperidone; QUAR F1/2, Dose 2 - Gluteal, Oral risperidone; QUAR F1/2, Dose 3 - Gluteal, Oral risperidone; QUAR F1/2, Dose 3 - Deltoids
Rovi Pharmaceuticals Laboratories
Schizophrenia
05/26
05/26
RESHAPE, NCT05480046: Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse

Recruiting
N/A
1200
Europe
Risperidone ISM, OKEDI®
Rovi Pharmaceuticals Laboratories
Schizophrenia
06/24
06/24

Download Options